LDL particle number and risk of future cardiovascular disease in the Framingham Offspring Study—Implications for LDL management
- 22 October 2007
- journal article
- research article
- Published by Elsevier BV in Journal of Clinical Lipidology
- Vol. 1 (6), 583-592
- https://doi.org/10.1016/j.jacl.2007.10.001
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Heterogeneity of Low-Density Lipoprotein Particle Number in Patients With Type 2 Diabetes Mellitus and Low-Density Lipoprotein Cholesterol <100 mg/dlThe American Journal of Cardiology, 2006
- Non–High-Density Lipoprotein and Very-Low-Density Lipoprotein Cholesterol and Their Risk Predictive Values in Coronary Heart DiseaseThe American Journal of Cardiology, 2006
- Assessment of Reaching Goal in Patients with Combined Hyperlipidemia: Low-Density Lipoprotein Cholesterol, Non–High-Density Lipoprotein Cholesterol, or Apolipoprotein BThe American Journal of Cardiology, 2005
- Reducing Residual Risk for Patients on Statin Therapy: The Potential Role of Combination TherapyThe American Journal of Cardiology, 2005
- Low-Density Lipoprotein Particle Concentration and Size as Determined by Nuclear Magnetic Resonance Spectroscopy as Predictors of Cardiovascular Disease in WomenCirculation, 2002
- Nuclear Magnetic Resonance Spectroscopy of Lipoproteins and Risk of Coronary Heart Disease in the Cardiovascular Health StudyArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trialThe Lancet, 2002
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Action of Atorvastatin in Combined HyperlipidemiaArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Short-Term Effects of Beta Blockers Atenolol, Nadolol, Pindolol, and Propranolol on Lipoprotein Metabolism in Normolipemic SubjectsThe Journal of Clinical Pharmacology, 1987